Sales & Marketing Media Partner Why BIO-Europe 2026 matters: The evolution of strategic biop... 2026 marks a significant evolution for BIO-Europe.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires, Jun... Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.
Sales & Marketing Sponsored Personalisation is the biggest lie brands keep telling Pharma brands need to move beyond surface-level personalisation and focus on measurable impact.
Sales & Marketing M&A trends in diagnostics and life sciences tools The diagnostics and life sciences tools sector is attracting continued investor interest across both private equity and large corporates.
Sales & Marketing What does FDA's proposed DTC advertising rule mean for pharm... Last month, the FDA quietly added a proposed rule to the 2026 Unified Agenda that – if finalised – could make prescription drug advertising untenable.
Sales & Marketing Why trust is becoming pharma’s most important visibility met... Any gap between an AI-generated answer and a product’s approved profile carries consequences for prescribing decisions and patient safety.
News Novartis sets sights on new oral MS drug after phase 3 wins Novartis' oral BTK inhibitor remibrutinib has shown efficacy in a pair of phase 3 trials in multiple sclerosis, boosting its blockbuster credentials.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
